Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Rifamycin SV After Sapphire FUE: Accelerated Wound Healing and Anticipatory and Preventive Nursing Care

NCT07155408 is registered in ClinicalTrials.gov with Elif Asena KANTARCI as lead sponsor.

NCT NCT07155408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Rifamycin SV After Sapphire FUE: Accelerated Wound Healing and Anticipatory and Preventive Nursing Care
Lead sponsor
Elif Asena KANTARCI
Phase
Not applicable
Overall status
Completed
Start date
December 2, 2021
Completion date
June 22, 2022
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia, wound healing